Drug Type Small molecule drug |
Synonyms Biapenem/RPX 7009, RPX7009/biapenem, RPX-2003/RPX-7009 + [2] |
Target |
Action inhibitors |
Mechanism PBPs inhibitors(Bacterial penicillin-binding protein inhibitors), β-lactamase inhibitors(Beta Lactamase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC12H16BNO5S |
InChIKeyIOOWNWLVCOUUEX-WPRPVWTQSA-N |
CAS Registry1360457-46-0 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Gram-Negative Bacterial Infections | Phase 1 | United States | - | |
| Gram-Negative Bacterial Infections | Phase 1 | Australia | - | |
| Gram-Negative Bacterial Infections | Phase 1 | - | - |





